As of 2025-07-03, the Relative Valuation of Innocan Pharma Corp (INNO.CN) is 0.03 CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.23 CAD, the upside of Innocan Pharma Corp based on Relative Valuation is -87.4%.
The range of the Relative Valuation is (0.00) - 0.09 CAD.
| Range | Selected | |
| Trailing P/E multiples | 0.1x - 2.0x | 0.1x |
| Forward P/E multiples | 7.7x - 15.3x | 9.6x |
| Fair Price | (0.00) - 0.09 | 0.03 |
| Upside | -100.1% - -59.7% | -87.4% |
| Date | P/E |
| 2025-06-30 | -72.72 |
| 2025-06-27 | -72.72 |
| 2025-06-26 | -72.72 |
| 2025-06-25 | -71.10 |
| 2025-06-24 | -72.72 |
| 2025-06-23 | -74.33 |
| 2025-06-20 | -74.33 |
| 2025-06-19 | -64.64 |
| 2025-06-18 | -71.10 |
| 2025-06-17 | -58.17 |
| 2025-06-16 | -56.56 |
| 2025-06-13 | -54.94 |
| 2025-06-12 | -54.94 |
| 2025-06-11 | -54.94 |
| 2025-06-10 | -51.71 |
| 2025-06-09 | -54.94 |
| 2025-06-06 | -54.94 |
| 2025-06-04 | -54.94 |
| 2025-06-03 | -54.94 |
| 2025-06-02 | -54.94 |
| 2025-05-29 | -54.94 |
| 2025-05-28 | -51.71 |
| 2025-05-27 | -51.71 |
| 2025-05-26 | -48.48 |
| 2025-05-23 | -51.71 |
| 2025-05-22 | -51.71 |
| 2025-05-21 | -51.71 |
| 2025-05-20 | -51.71 |
| 2025-05-16 | -54.94 |
| 2025-05-15 | -53.33 |
| 2025-05-14 | -53.33 |
| 2025-05-13 | -54.94 |
| 2025-05-12 | -51.71 |
| 2025-05-09 | -54.94 |
| 2025-05-08 | -56.56 |
| 2025-05-07 | -58.17 |
| 2025-05-06 | -58.17 |
| 2025-05-05 | -51.71 |
| 2025-05-02 | -53.33 |
| 2025-05-01 | -51.71 |
| 2025-04-30 | -54.94 |
| 2025-04-29 | -54.94 |
| 2025-04-28 | -54.94 |
| 2025-04-25 | -53.33 |
| 2025-04-24 | -54.94 |
| 2025-04-23 | -58.17 |
| 2025-04-22 | -58.17 |
| 2025-04-21 | -58.17 |
| 2025-04-17 | -58.17 |
| 2025-04-16 | -58.17 |